ArticlePoultry science2026
Dietary supplementation with Cuscuta chinensis improves ovarian function and production performance in aged laying hens via modulation of steroid hormone biosynthesis and gut microbiota.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Declining reproductive performance due to ovarian aging is a critical challenge in layer farming. This study investigated the mechanism by which Cuscuta chinensis (TSZ), a herb with known estrogen-like activity, improves ovarian function in aged laying hens. Network pharmacology analysis identified ten candidate anti-ovarian aging compounds in TSZ, with IL-1B, IL-6, and EGF predicted as core targets. Subsequently, an 8-week feeding trial was conducted using 432 healthy 46-week-old Jing Brown 1 laying hens, which were randomly assigned to four groups and were fed a basal diet supplemented with 0%, 0.5%, 1%, or 2% TSZ. An integrated multi-omics approach-combining serum metabolomics, ovarian transcriptomics, and cecal 16S rRNA sequencing-was employed to systematically map the responsive pathways. Dietary TSZ significantly reduced the rate of abnormal eggs and increased Haugh unit values (P < 0.05), with the 0.5% supplementation group showing optimal overall production performance. TSZ significantly increased serum levels of estradiol and follicle-stimulating hormone (P < 0.05), up-regulated ovarian estrogen receptor gene expression, and down-regulated pro-inflammatory cytokine genes in the ovary (P < 0.05). Integrated omics analysis revealed activation of the ovarian steroid hormone biosynthesis pathway. Furthermore, TSZ reshaped the cecal microbiota structure, notably enriching butyrate-producing bacteria such as Butyricicoccus pullicaecorum and Butyricimonas, whose abundances correlated positively with multiple steroid hormone-related metabolites. Collectively, these results demonstrated that TSZ improved ovarian function in aging hens by modulating estrogen signaling, suppressing local ovarian inflammation, and promoting steroidogenesis-effects that were closely linked to TSZ-mediated restructuring of the gut microbiota and regulation of the gut-ovary axis. This work provides a mechanistic foundation for developing TSZ as a natural feed additive to mitigate reproductive aging in laying hens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.